×
Innoviva EBIT 2012-2026 | INVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Innoviva ebit from 2012 to 2026. Ebit can be defined as earnings before interest and taxes.
View More
Innoviva EBIT 2012-2026 | INVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Innoviva ebit from 2012 to 2026. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$887.6B
Johnson & Johnson (JNJ)
$574.4B
AbbVie (ABBV)
$367.7B
Roche Holding AG (RHHBY)
$318.8B
Merck (MRK)
$299.9B
Novartis AG (NVS)
$294B
Novo Nordisk (NVO)
$167.5B
Pfizer (PFE)
$153.1B
Sanofi (SNY)
$114B
Bayer (BAYRY)
$46.2B